scholarly journals Analysis of Acute Toxicity(LD50-Value) of Organic Chemicals to Mammals by Solubility Parameter(.DELTA.). (3). Acute Dermal Toxicity to Rabbits.

Sangyo Igaku ◽  
1994 ◽  
Vol 36 (6) ◽  
pp. 428-434
Author(s):  
Hiroshi NISHIMURA ◽  
Shoji SAITO ◽  
Fumio KISHIDA ◽  
Masatoshi MATSUO
2011 ◽  
Vol 103 (1-2) ◽  
pp. 38-45 ◽  
Author(s):  
Roman Ashauer ◽  
Anita Hintermeister ◽  
Eva Potthoff ◽  
Beate I. Escher

2021 ◽  
Vol 46 (2) ◽  
Author(s):  
C. Imoisi ◽  
J.U. Iyasele ◽  
S.E. Okhale

The fresh fruits of Vitex doniana sweet were collected from several randomly selected trees in a farm site in Uromi metropolis, Esan North-East Local Government Area of Edo state and then processed into an extract in form of syrup. The proximate composition and acute toxicity profile of Vitex doniana sweet fruit were investigated to ascertain its safety and nutritional capability. Analysis of the fruit showed it to be a highly nutritious food containing moisture of about, 9.90%, ash content: 21.5%, fat: 0.75%, fiber: Not detected (ND), protein: 0.006% and carbohydrate: 67.84%. Twenty mice were randomized based on body weight into five groups of four mice each. Three mice in each group were given syrup volumes of 100, 200, 300, 400 and 500 mg/ml respectively, corresponding to 1000, 2000, 3000, 4000 and 5000 mg/kg doses. In contrast, mice in the control group received potable water (10 mL/kg). The mice in all the groups were observed closely for mortality, toxicity signs and abnormalities in gross behaviour at 15 min, 30 min, 1, 2, 4 and 8 h, and then daily for 14 days. Based on the model used, the fruit was acutely safe in mice, since no death was observed within 24 hours after oral treatment and on extrapolation gave a high predictive value in humans. The LD50 value of black plum fruit was also found to be greater than 5000 mg/kg. Therefore, Vitex doniana fruit should be considered a source of edible syrup bearing in mind the safety, quantity and variety of nutrients it contains.


2019 ◽  
Vol 8 (6) ◽  
pp. 862-867 ◽  
Author(s):  
Jin Wang ◽  
Yu-Ting Wang ◽  
Yan Fang ◽  
Yan-Li Lu ◽  
Ming-Xue Li

Abstract In this article, three organotin complexes formulated as [(Me)2Sn(H2L1)] (1), [(Ph)2Sn(H2L1)]·MeOH (2) and [(Me)2Sn(HL2)(OAc)]4(Me)2O (3) (H4L1 = bis(2-hydroxybenzaldehyde) thiocarbohydrazone and H2L2 = bis(2-acetylpyrazine) thiocarbonohydrazone) have been synthesized and structurally characterized. Growth inhibition assays indicated that both the proligands and the three complexes are capable of showing anticancer activity against the human hepatocellular carcinoma HepG2 cells with H2L2 and complex 3 showing much higher cytotoxic potential. Subsequent toxicity studies on normal QSG7701cells showed that complex 3 has the highest tumor cell selectivity, and its IC50 value on QSG7701 cells is 8.48 fold higher than that in HepG2 cells. In acute toxicity experiments, complex 3 produces a dose-dependent effect in NIH mice with a LD50 value of 17.2 mg kg−1.


1988 ◽  
Vol 12 (1) ◽  
pp. 33-38 ◽  
Author(s):  
J.W. Deneer ◽  
T.L. Sinnige ◽  
W. Seinen ◽  
J.L.M. Hermens

2021 ◽  
Author(s):  
Fabrícia da Cunha Jácome Marques ◽  
Francisco Glerison da Silva Nascimento ◽  
Dayanne Terra Tenório Nonato ◽  
Amaurílio Oliveira Nogueira ◽  
Iásly Costa Lima ◽  
...  

Abstract Galactomannans from Caesalpinia pulcherrima (GM-CP) and Delonix regia (GM-DR) are being pointed as potential therapeutic agents, but systematic evaluations on their acute toxicity are yet to be reported. In order to evaluate the occurrence of systemic toxicity, groups of three female rats received oral GM-CP or GM-DR (300 mg kg-1), whereas the control group received vehicle. Since lethality was absent, other groups received doses of 2,000 mg kg-1, which also did not cause lethality. Collection of organs and blood samples were done at day 14. Dermal toxicity of the galactomannans was also evaluated (2,000 mg kg-1, n=3 per group), as well both mechanical hypernociception and inflammatory cell influx after administration of GM-CP or GM-DR via intra-articular route (200 µg, n = 5 per group). At the routes and doses employed, both galactomannans did not evoke physiological / behavioral changes or skin / joint inflammation. Since the LD50 was not inferior to 2,000 mg kg-1, both galactomannans are in the class 5 of the Globally Harmonized System for Classification and Labelling of Chemicals.


2004 ◽  
Vol 28 (1) ◽  
pp. 190-199
Author(s):  
Duraid A. Abbas

 Comparative studies about the characteristics of the acute toxicity of streptomycin and gentamicin and the antagonization effect of calcium to their toxicity were performed in mice. This was made by comparing the time of appearance and disappearance of toxicity symptoms of this aminoglycoside before and after calcium therapy and also by comparing the LD50 value of both agents. It was concluded that streptomycin is less potent but more efficacious as toxic agent than gentamicin and that calcium had a competitive inhibitory effect to the toxicity of aminoglycoside perhaps because of the similarity in their charges and binding sites.  Calcium therapy seems to offer quantitatively the same protective level for both agents (nearly one time) but qualitatively better protective level against acute toxicity of streptomycin in mice than for gentamicin.


2020 ◽  
Vol 13 (5) ◽  
pp. 81 ◽  
Author(s):  
Andrey E. Shchekotikhin ◽  
Helen M. Treshalina ◽  
Michael I. Treshchalin ◽  
Eleonora R. Pereverzeva ◽  
Helen B. Isakova ◽  
...  

The new antitumor agent anthrafuran has demonstrated a consistent effect in murine tumor models when administered parenterally due to the simultaneous inhibition of multiple cellular targets such as topoisomerases I/II and protein kinases. In this study, we assessed the anticancer efficiency and acute toxicity of anthrafuran administered orally. The action of anthrafuran was studied on transplanted tumor models which included P388 leukemia, Ca755 mammary adenocarcinoma, LLC lung carcinoma, and T47D human breast cancer xenografts on Balb/c nude mice. A significant antitumor efficacy of oral anthrafuran was revealed for all tested tumor models as follows: T/Cmax = 219% for P388, TGImax = 91% for Ca755, TGImax = 84% with CRmax = 54% for LLC, and T/C = 38% for T47D. The optimal treatment schedule of orally administered anthrafuran was 70–100 mg/kg given daily for five days. The LD50 value of orally administered anthrafuran (306.7 mg/kg) in mice was six times higher than that for i.p. administration (52.5 mg/kg). The rates of antitumor efficacy and acute toxicity indicate the high potential for further research on anthrafuran as a new original oral anticancer multitarget agent with an expected satisfactory tolerability and bioavailability.


Sign in / Sign up

Export Citation Format

Share Document